hydroxyzine bluefish 25 mg
bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 25 mg
hydroxyzine bluefish 10 mg
bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 10 mg
numient
amneal pharma europe ltd - levodopa, carbidopa - parkinsonsykdom - anti-parkinson medisiner - symptomatisk behandling av voksne pasienter med parkinsons sykdom.
bettamousse 1 mg/ g
rph pharmaceuticals ab - betametasonvalerat - skum - 1 mg/ g
anagrelide aop 0.5 mg
aop orphan pharmaceuticals gmbh - anagrelidhydroklorid monohydrat - kapsel, hard - 0.5 mg
briumvi
neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
dicloxacillin bluefish 500 mg
bluefish pharmaceuticals ab - dikloksacillinnatrium - kapsel, hard - 500 mg
dicloxacillin bluefish 250 mg
bluefish pharmaceuticals ab - dikloksacillinnatrium - kapsel, hard - 250 mg
artesunate amivas
amivas ireland ltd - artesunate - malaria - antiprotozoals - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. det bør vurderes å offisielle retningslinjer for riktig bruk av agenter antimalariamidler.